Clinical Trial Update: Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase I study evaluating perifosine in combination with sorafenib in patients with advanced cancers, including renal c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Perifosine (perifosine)
• Sorafenib (Sorafenib)

Snippet

Sponsor: AEterna Zentaris | Conditions: Renal Cancer, Tumors | Phase 1 | Status: COMPLETED